24 results
S-3
EX-1.2
CADL
Candel Therapeutics Inc
5 Aug 22
Shelf registration
5:08pm
or any committee thereof or from any other U.S. or foreign government or drug regulatory agency, or health care facility Institutional Review Board … for any other “at the market” or continuous equity transaction.
(ss) Compliance with Health Care Laws. The Company and its subsidiaries are, and at all
S-1/A
EX-1.1
CADL
Candel Therapeutics Inc
16 Jul 21
IPO registration (amended)
6:07am
government or drug or medical device regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies … rules and regulations of the Regulatory Agencies.
(uu) Compliance with Health Care Laws. The Company and its subsidiaries are, and at all times have
8-K
EX-99.1
CADL
Candel Therapeutics Inc
1 Aug 22
Candel Therapeutics Appoints Three New Members to its Board of Directors
6:09am
years of experience in the pharmaceutical, health care and specialty pharmaceutical industries, including more than 20 years of branded prescription
10-K
2021 FY
EX-10.11
CADL
Candel Therapeutics Inc
29 Mar 22
Annual report
8:46am
respective businesses and Borrower has not been debarred or excluded from participation under a state or federal health care program, including any state … ) all goods, Accounts (including health-care receivables), Equipment, Inventory, contract rights or rights to payment of money, leases, license
S-1/A
EX-10.5.3
CADL
Candel Therapeutics Inc
16 Jul 21
IPO registration (amended)
6:07am
result in a violation of applicable law (including but not limited to the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health … Care and Education Reconciliation Act), then in lieu of paying COBRA premiums pursuant to this Section, the Company shall pay the Employee on the last
S-1/A
EX-10.5.2
bcqi5q
16 Jul 21
IPO registration (amended)
6:07am
10-Q
cci19p9
8 Sep 21
Quarterly report
8:37am
S-1
ohx3 ni4jv
25 Jun 21
IPO registration
5:28pm
DRS/A
vxsjmq1exa3 xq9
31 Mar 21
Draft registration statement (amended)
12:00am
S-1/A
70macimzqf5c
16 Jul 21
IPO registration (amended)
6:07am
424B4
o59ib0a7ctjhwip
28 Jul 21
Prospectus supplement with pricing info
4:02pm